U.S. Physical Therapy, Inc. (USPH) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026

U.S. Physical Therapy, Inc. · Health Care · ref. ETF XLV · 50 calls · price $79.1

🏆JPI 2026 portfoliosSee tracking →

What the company does: U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics.

📈 U.S. Physical Therapy, Inc. (USPH) stock price

$79.1-4.4% over range

Aug 28, 25low $59 · high $93.16Aug 27, 26

📏 Click 2 points (left → right) to measure the change · click again to clear.

SellBuy

Buy

100% recommend buying · 2 analysts

📊 JPI status : U.S. Physical Therapy, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 USPH price target & analyst consensus — price $79.10

The price target · all analysts combined (2 targets)

Highest target · 2 firms of 2$98+23.9%

Median target · of 2 targets$98+23.9%

Lowest target · 2 firms of 2$98+23.9%

Current price$79.1

⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 2 ratings (last 6 months)

Strong Buy00%

Buy2100%

Hold00%

Sell00%

Strong Sell00%

Go deeper on the analysts

🎯 USPH price target all

All 50 calls, one by one, with our verdict on each firm.

→ See all 50 targets, analyst by analyst

💡 The best analysts on USPH most reliable

Their real reliability on USPH, firm by firm: who was right, who was wrong.

→ See their reliability on USPH

All analysts (the consensus) · vs · the best (those who've been right)

💬 A question about U.S. Physical Therapy, Inc.? The JPI assistant answers using our backtest data.

🏛️ U.S. Physical Therapy, Inc. insider buying: who's buying and how much › open the full page

1 insider bought1 buys / 6 mo $49k

🔎 Detailed analyses

📊 Returns & performance 🏛️ Insider buying

🏛️ Which US Congress members hold U.S. Physical Therapy, Inc. (USPH)?

1 Congress member has disclosed USPH buys. Click a highlighted name to see their track record (do they beat the S&P 500?).

Josh Gottheimer 1× · 56%

→ Full members ranking (who beats the market)

✅ Historical analyst reliability on USPH

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕	% right i ↕	Gain vs sector i ↕	Calls i ↕
Jefferies ↗	80%	+8.4%	5
JMP Securities	50%	-3.3%	2
Barrington Research ↗	40%	-3.9%	20
JP Morgan ↗	20%	-12.3%	5
CJS Securities	0%	-10.9%	2
B of A Securities ↗	0%	-21.3%	2

📊 What $1,000 invested in U.S. Physical Therapy, Inc. would be worth › open the full page

In short — $1,000 invested in U.S. Physical Therapy, Inc. 10 years ago would be worth $1,304 today, i.e. +3%/yr on average. Best year: 2018 (+42%), worst: 2021 (-21%). Price performance, excluding dividends.

If I'd invested $1,000 in U.S. Physical Therapy, Inc.

Investment	Worth today	Gain
1 years ago	$789	-21%
3 years ago	$864	-14%
5 years ago	$582	-42%

→ See U.S. Physical Therapy, Inc.'s full return history + gain calculator

Return by year (U.S. Physical Therapy, Inc.)

Year	Return	$1,000 invested at year start
2026 (YTD)	-10%	$896 (-10%)
2025	-12%	$789 (-21%)
2024	-5%	$752 (-25%)

→ See U.S. Physical Therapy, Inc.'s full return history + gain calculator

⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on U.S. Physical Therapy, Inc.

Loading news…

📋 All analyst calls on USPH

Barrington Research ↗

Aug 10, 26

▲ Outperform · 🎯$98

Price at call : $81.74 — upside +20%

Today : $79.1 — upside +24%

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

in progress (365j)
matures : Aug 10, 27

Citizens

Jun 24, 26

▲ Market Outperform · 🎯$98

Price at call : $66.21 — upside +48%

Today : $79.1 — upside +24%

🎯 on USPH : no call matured yet · 📊 unranked overall

in progress (365j)
matures : Jun 24, 27

Barrington Research ↗

May 13, 26

▲ Outperform · 🎯$90

Price at call : $60.14 — upside +50%

Today : $79.1 — upside +14%

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

in progress (365j)
matures : May 13, 27

Citizens

May 8, 26

▲ Market Outperform · 🎯$98

Price at call : $59.42 — upside +65%

Today : $79.1 — upside +24%

🎯 on USPH : no call matured yet · 📊 unranked overall

in progress (365j)
matures : May 8, 27

Barrington Research ↗

Feb 20, 26

▲ Outperform · 🎯$103

Price at call : $85.09 — upside +21%

Today : $79.1 — upside +30%

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

in progress (365j)
matures : Feb 20, 27

Barrington Research ↗

Jan 5, 26

▲ Outperform · 🎯$103

Price at call : $81.25 — upside +27%

Today : $79.1 — upside +30%

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

in progress (365j)
matures : Jan 5, 27

JP Morgan ↗

Nov 24, 25

▲ Overweight · 🎯$100

Price at call : $74.16 — upside +35%

Today : $79.1 — upside +26%

🎯 on USPH : 20% (5 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)

in progress (365j)
matures : Nov 24, 26

Barrington Research ↗

Oct 24, 25

▲ Outperform · 🎯$103

Price at call : $93.16 — upside +11%

Today : $79.1 — upside +30%

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

in progress (365j)
matures : Oct 24, 26

See the other 42 calls, newest to oldest

Barrington Research ↗

Aug 8, 25

▲ Outperform · 🎯$103

Price at call : $87.68 — upside +17%

Today : $79.1 — upside +30%

Expected +17% · Actual -7% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

-6.8%

stock -7% · XLV +29%

matured Aug 8, 26

Barrington Research ↗

Jul 1, 25

▲ Outperform · 🎯$98

Price at call : $80.61 — upside +22%

Today : $79.1 — upside +24%

Expected +22% · Actual -12% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

-11.5%

stock -12% · XLV +17%

matured Jul 1, 26

JMP Securities

Apr 22, 25

▲ Market Outperform · 🎯$113

Price at call : $67.87 — upside +66%

Today : $79.1 — upside +43%

Expected +66% · Actual +11% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 50% (2 calls matureds) · 📊 unranked overall

+11.3%

stock +11% · XLV +8%

matured Apr 22, 26

JP Morgan ↗

Mar 19, 25

▲ Overweight · 🎯$110

Price at call : $74.69 — upside +47%

Today : $79.1 — upside +39%

Expected +47% · Actual -1% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 20% (5 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)

-1.1%

stock -1% · XLV -1%

matured Mar 19, 26

Barrington Research ↗

Feb 28, 25

▲ Outperform · 🎯$98

Price at call : $81.02 — upside +21%

Today : $79.1 — upside +24%

Expected +21% · Actual +2% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

+2.5%

stock +2% · XLV +6%

matured Feb 28, 26

B of A Securities ↗

Dec 16, 24

▲ Buy · 🎯$115

Price at call : $95.56 — upside +20%

Today : $79.1 — upside +45%

Expected +20% · Actual -18% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 0% (2 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)

-17.8%

stock -18% · XLV +11%

matured Dec 16, 25

JMP Securities

Dec 16, 24

▲ Market Outperform · 🎯$113

Price at call : $95.56 — upside +18%

Today : $79.1 — upside +43%

Expected +18% · Actual -18% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 50% (2 calls matureds) · 📊 unranked overall

-17.8%

stock -18% · XLV +11%

matured Dec 16, 25

JP Morgan ↗

Dec 3, 24

▲ Overweight · 🎯$120

Price at call : $99.91 — upside +20%

Today : $79.1 — upside +52%

Expected +20% · Actual -24% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 20% (5 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)

-23.6%

stock -24% · XLV +5%

matured Dec 3, 25

Barrington Research ↗

Nov 21, 24

▲ Outperform · 🎯$108

Price at call : $97.83 — upside +10%

Today : $79.1 — upside +37%

Expected +10% · Actual -27% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

-26.9%

stock -27% · XLV +8%

matured Nov 21, 25

Barrington Research ↗

Nov 7, 24

▲ Outperform · 🎯$108

Price at call : $95.08 — upside +14%

Today : $79.1 — upside +37%

Expected +14% · Actual -23% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

-22.9%

stock -23% · XLV -2%

matured Nov 7, 25

Barrington Research ↗

Oct 9, 24

▲ Outperform · 🎯$108

Price at call : $77.52 — upside +39%

Today : $79.1 — upside +37%

Expected +39% · Actual +13% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

+13.2%

stock +13% · XLV -7%

matured Oct 9, 25

B of A Securities ↗

Oct 7, 24

■ Neutral neutral · not a buy · 🎯$90

Price at call : $78.49 — gap to target +15%

Today : $79.1 — gap to target +14%

🎯 on USPH : 0% (2 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)

in progress (365j)
matures : Oct 7, 25

Barrington Research ↗

Sep 20, 24

▲ Outperform · 🎯$108

Price at call : $83.05 — upside +30%

Today : $79.1 — upside +37%

Expected +30% · Actual -4% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

-3.8%

stock -4% · XLV -12%

matured Sep 20, 25

Barrington Research ↗

Aug 15, 24

▲ Outperform · 🎯$108

Price at call : $84.21 — upside +28%

Today : $79.1 — upside +37%

Expected +28% · Actual +0% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

+0.1%

stock +0% · XLV -11%

matured Aug 15, 25

Barrington Research ↗

May 9, 24

▲ Outperform · 🎯$122

Price at call : $106.39 — upside +15%

Today : $79.1 — upside +54%

Expected +15% · Actual -27% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

-27.3%

stock -27% · XLV -5%

matured May 9, 25

JP Morgan ↗

Mar 13, 24

▲ Overweight · 🎯$117

Price at call : $107.68 — upside +9%

Today : $79.1 — upside +48%

Expected +9% · Actual -29% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 20% (5 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)

-28.5%

stock -29% · XLV -2%

matured Mar 13, 25

Barrington Research ↗

Mar 1, 24

▲ Outperform · 🎯$122

Price at call : $105.67 — upside +15%

Today : $79.1 — upside +54%

Expected +15% · Actual -25% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

-24.6%

stock -25% · XLV +2%

matured Mar 1, 25

Barrington Research ↗

Jan 3, 24

▲ Outperform · 🎯$120

Price at call : $93.32 — upside +29%

Today : $79.1 — upside +52%

Expected +29% · Actual -6% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

-5.5%

stock -6% · XLV -0%

matured Jan 2, 25

JP Morgan ↗

Nov 17, 23

▲ Overweight · 🎯$99

Price at call : $86.06 — upside +15%

Today : $79.1 — upside +25%

Expected +15% · Actual +5% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 20% (5 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)

+4.5%

stock +5% · XLV +10%

matured Nov 16, 24

Barrington Research ↗

Nov 9, 23

▲ Outperform · 🎯$111

Price at call : $82.37 — upside +35%

Today : $79.1 — upside +40%

Expected +35% · Actual +15% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

+14.9%

stock +15% · XLV +18%

matured Nov 8, 24

JP Morgan ↗

Sep 22, 23

▲ Overweight · 🎯$108

Price at call : $95.33 — upside +13%

Today : $79.1 — upside +37%

Expected +13% · Actual -13% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 20% (5 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)

-12.9%

stock -13% · XLV +19%

matured Sep 21, 24

CJS Securities

Sep 19, 23

▲ Market Outperform

Actual -12% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 0% (2 calls matureds) · 📊 on Health : 50% · +29.5% (6 calls)

-11.9%

stock -12% · XLV +19%

matured Sep 18, 24

Barrington Research ↗

Aug 14, 23

▲ Outperform · 🎯$124

Price at call : $107.08 — upside +16%

Today : $79.1 — upside +57%

Expected +16% · Actual -16% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

-16.0%

stock -16% · XLV +11%

matured Aug 13, 24

B of A Securities ↗

Jun 30, 23

▲ Buy · 🎯$138

Price at call : $121.39 — upside +14%

Today : $79.1 — upside +74%

Expected +14% · Actual -25% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 0% (2 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)

-24.8%

stock -25% · XLV +9%

matured Jun 29, 24

Barrington Research ↗

May 5, 23

▲ Outperform · 🎯$116

Price at call : $114.29 — upside +1%

Today : $79.1 — upside +47%

Expected +1% · Actual -7% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

-7.1%

stock -7% · XLV +6%

matured May 4, 24

Barrington Research ↗

Feb 24, 23

▲ Outperform · 🎯$110

Price at call : $99.77 — upside +10%

Today : $79.1 — upside +39%

Expected +10% · Actual +1% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

+1.1%

stock +1% · XLV +15%

matured Feb 24, 24

CJS Securities

Dec 14, 21

▲ Market Outperform · 🎯$120

Price at call : $95.72 — upside +25%

Today : $79.1 — upside +52%

Expected +25% · Actual -10% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 0% (2 calls matureds) · 📊 on Health : 50% · +29.5% (6 calls)

-10.0%

stock -10% · XLV -0%

matured Dec 14, 22

Barrington Research ↗

May 7, 21

▲ Outperform · 🎯$130

Price at call : $118.18 — upside +10%

Today : $79.1 — upside +64%

Expected +10% · Actual -14% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

-13.6%

stock -14% · XLV +2%

matured May 7, 22

Jefferies ↗

May 3, 21

▲ Buy · 🎯$135

Price at call : $117.58 — upside +15%

Today : $79.1 — upside +71%

Expected +15% · Actual -14% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)

-13.9%

stock -14% · XLV +6%

matured May 3, 22

Barrington Research ↗

Feb 26, 21

■ Market Perform neutral · not a buy

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

in progress (365j)
matures : Feb 26, 22

Sidoti & Co.

Mar 27, 20

▲ Buy · 🎯$80

Price at call : $69.3 — upside +15%

Today : $79.1 — upside +1%

Expected +15% · Actual +50% · Reason (≥ +15%) : ✓ Yes

🎯 on USPH : 100% (1 call matured) · 📊 on Health : 54.2% · +25.8% (24 calls)

+49.9%

stock +50% · XLV +32%

matured Mar 27, 21

Barrington Research ↗

Nov 8, 19

▲ Outperform · 🎯$130

Price at call : $117.5 — upside +11%

Today : $79.1 — upside +64%

Expected +11% · Actual -5% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

-5.0%

stock -5% · XLV +17%

matured Nov 7, 20

William Blair ↗

Mar 8, 19

▲ Outperform

Actual -8% · Reason (≥ +15%) : ✗ No

🎯 on USPH : 0% (1 call matured) · 📊 on Health : 32% · -10.8% (25 calls)

-8.4%

stock -8% · XLV +3%

matured Mar 7, 20

Cantor Fitzgerald ↗

Nov 2, 18

■ Neutral neutral · not a buy · 🎯$107

Price at call : $114.27 — gap to target -6%

Today : $79.1 — gap to target +35%

🎯 on USPH : 100% (1 call matured) · 📊 on Health : 50.6% · +13.8% (166 calls)

in progress (365j)
matures : Nov 2, 19

Cantor Fitzgerald ↗

May 4, 18

■ Neutral neutral · not a buy

🎯 on USPH : 100% (1 call matured) · 📊 on Health : 50.6% · +13.8% (166 calls)

in progress (365j)
matures : May 4, 19

Barrington Research ↗

Nov 3, 17

■ Market Perform neutral · not a buy

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

in progress (365j)
matures : Nov 3, 18

Cantor Fitzgerald ↗

Jul 25, 17

▲ Overweight · 🎯$72

Price at call : $66.75 — upside +8%

Today : $79.1 — upside -9%

Expected +8% · Actual +59% · Reason (≥ +15%) : ✓ Yes

🎯 on USPH : 100% (1 call matured) · 📊 on Health : 50.6% · +13.8% (166 calls)

+58.7%

stock +59% · XLV +11%

matured Jul 25, 18

Barrington Research ↗

Mar 17, 17

■ Market Perform neutral · not a buy

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

in progress (365j)
matures : Mar 17, 18

Barrington Research ↗

Nov 4, 16

▲ Outperform

Actual +20% · Reason (≥ +15%) : ✓ Yes

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

+19.6%

stock +20% · XLV +22%

matured Nov 4, 17

Jefferies ↗

Aug 5, 16

■ Hold neutral · not a buy · 🎯$65

Price at call : $60.38 — gap to target +8%

Today : $79.1 — gap to target -18%

🎯 on USPH : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)

in progress (365j)
matures : Aug 5, 17

Barrington Research ↗

May 6, 16

▲ Outperform

Actual +19% · Reason (≥ +15%) : ✓ Yes

🎯 on USPH : 37% (19 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)

+18.6%

stock +19% · XLV +9%

matured May 6, 17

Jefferies ↗

Mar 1, 16

■ Hold neutral · not a buy

🎯 on USPH : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)

in progress (365j)
matures : Mar 1, 17

Frequently asked questions

Should I buy U.S. Physical Therapy, Inc. stock?

This isn't buy advice. For U.S. Physical Therapy, Inc., the analyst consensus is "Buy", with an average price target of $98.00 (+24% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 80% of the time (5 calls tracked on U.S. Physical Therapy, Inc.). We show the numbers — you decide.

Is it too late to buy U.S. Physical Therapy, Inc.? How high can it go?

The most bullish analyst target on U.S. Physical Therapy, Inc. is $98.00 (+24% above today's price); the average is $98.00. That's the upside they see. Check how reliable those analysts have actually been on U.S. Physical Therapy, Inc. on our site before trusting it.

Is U.S. Physical Therapy, Inc. still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 6 analysts have a real record on U.S. Physical Therapy, Inc., the best hitting 80% over 5 calls. Current consensus: "Buy". Make your call on data, not noise.

What has U.S. Physical Therapy, Inc.'s past performance been?

Historical returns and a "how much if I had invested" calculator: USPH performance & returns.

Are insiders buying USPH stock?

Executives' and large holders' buys and sells, decoded: insider buying on USPH.